Tether’s gold stash tops $23 billion as buying outpaces nation states, Jefferies says
Tether, the crypto firm behind the world’s most popular stablecoin USDT$0.9994, continued its gold hoarding over the past month, ranking…
Tag: Jefferies
Jefferies Lifts Price Target on General Dynamics Corporation (GD) to $385, Maintains Hold Rating
General Dynamics Corporation (NYSE:GD) is among the 10 best American defense stocks to buy according to Wall Street analysts. On…
Jefferies Reiterates Buy on The Boeing Company (BA) Following Q4 Results
The Boeing Company (NYSE:BA) is among the 10 best American defense stocks to buy according to Wall Street analysts. On…
Jefferies sees few signs of a BTC bottom yet flags upside for tokens with fundamentals
Jefferies says the latest crypto selloff shows few signs of an imminent bottom, even as bitcoin and ether hover near…
Jefferies Lifts Bloom Energy (BE) Target to $92 Amid Stronger 2026 Forecast, Keeps Underperform
Bloom Energy Corporation (NYSE:BE) is one of the AI Stocks in Focus on Wall Street. On January 26, Jefferies analyst…
Jefferies sees market structure bill as tokenization inflection point, despite rocky path ahead
Jefferies, a Wall Street investment bank, said maturing blockchain infrastructure and incremental regulatory progress are laying the groundwork for a…
Jefferies Keeps its Hold Rating on Pan American Silver Corp. (PAAS)
Pan American Silver Corp. (NYSE:PAAS) is among the 15 Best Performing Silver Stocks to Buy. Jefferies Keeps its Hold Rating…
Jefferies Assigns Buy Rating to monday.com (MNDY)
monday.com Ltd. (NASDAQ:MNDY) is one of the best software application stocks to buy according to Hedge Funds. On January 15,…
Jefferies strategist Christopher Wood swaps bitcoin for gold on quantum computing concern
Christopher Wood, Jefferies’ global head of equity strategy, swapped a 10% bitcoin allocation with gold on concern quantum computing could…
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why
GSK plc (NYSE:GSK) is one of the best performing pharma stocks in 2025. Jefferies reaffirmed a Buy rating on GSK…